BusinessNewLink Genetics Announces FDA Orphan-Drug Designation for IndoximodBy Nasdaq OMXOct 30, 2017, 1:01 PM UTC
BusinessKraig Biocraft Laboratories to Develop New Custom Recombinant Spider Silk under Contract with US ArmyBy Nasdaq OMXOct 30, 2017, 10:05 AM UTC
BusinessImmune Design to Report Third Quarter 2017 Financial Results & Provide Corporate UpdateBy Nasdaq OMXOct 27, 2017, 12:00 PM UTC
BusinessBioCryst Announces Late Breaker Presentation of BCX7353 Phase 2 APeX-1 Trial Results at the ACAAI’s 2017 Annual Scientific MeetingBy Nasdaq OMXOct 27, 2017, 10:00 AM UTC
BusinessBeyondSpring Announces the First Patient Enrolled in China in its Global Phase 2/3 Trial with Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaBy Nasdaq OMXOct 26, 2017, 12:31 PM UTC
BusinessEndoPredict (EPclin) Shown in Second Study to be More Effective than Oncotype DX® (RS) in Women with Intermediate Risk of Breast Cancer RecurrenceBy Nasdaq OMXOct 26, 2017, 11:05 AM UTC
BusinessApricus Biosciences Announces Corporate Update and Third Quarter 2017 Financial Results Conference CallBy Nasdaq OMXOct 26, 2017, 11:00 AM UTC
BusinessVital Therapies Announces Third Quarter 2017 Financial ResultsBy Nasdaq OMXOct 25, 2017, 8:01 PM UTC
